Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.
Axinn Attorneys Attending the 2026 IBA Conference
What Sets Us Apart
- Antitrust: Our team has a track record of obtaining global clearance of combinations of significant rivals, making us a “go-to” firm for strategic mergers and acquisitions.
- Intellectual Property: We are experienced trial lawyers who deliver favorable results in patent and trade secret trials, appeals, and before the U.S. Patent Office.
- Litigation: We are lead defense counsel to some of the world’s largest companies in high-stakes treble damages, class action, and multi-district litigations, as well as federal and state investigations.
Notable Recognitions
Featured Viewpoints
Featured Viewpoints
Another HSR Penalty Record: KKR’s $250 Million Settlement
Will New DOJ Timing Agreement Deliver Faster Merger Clearances?
FTC Prescribes Lower Out-of-Pocket Insulin Costs in Settlement with Caremark
What's the Skinny on SCOTUS' Skinny Label Decision?
Webinar
The FTC’s Record $12 Million HSR Penalty: Deal Structuring, Avoidance, and the Line Between Them
Too Much or Not Enough? Healthcare Organizations Comment on the New HSR Form
The Skinny Line Between Possible and Plausible
